• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于保护动机理论的 COVID-19 加强针接种接受度:中国的一项横断面研究。

Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China.

机构信息

School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.

Huadu Center for Disease Control and Prevention, Guangzhou, China.

出版信息

J Med Virol. 2022 Sep;94(9):4115-4124. doi: 10.1002/jmv.27825. Epub 2022 May 9.

DOI:10.1002/jmv.27825
PMID:35506329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9348068/
Abstract

The promotion of the booster shots against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an open issue to be discussed. Little is known about the public intention and the influencing factors regarding the booster vaccine. A cross-sectional survey in Chinese adults was conducted using an online questionnaire, which designed on the basis of protection motivation theory (PMT) scale and vaccine hesitancy scale (VHS). Hierarchical multiple regression was used to compare the fitness of the PMT scale and VHS for predicting booster vaccination intention. Multivariable logistic regression was used to analyze the factors associated with the acceptance. Six thousand three hundred twenty-one (76.8%) of participants were willing to take the booster shot. However, the rest of the participants (23.2%) were still hesitant to take the booster vaccine. The PMT scale was more powerful than the VHS in explaining the vaccination intention. Participants with high perceived severity (adjusted odds ratio [aOR] = 0.69) and response cost (aOR = 0.47) were less willing to take the booster shots, but participants with high perceived susceptibility (aOR = 1.19), response efficacy (aOR = 2.13), and self-efficacy (aOR = 3.33) were more willing to take the booster shots. In summary, interventions based on PMT can provide guidance to ensure the acceptance of the booster vaccine.

摘要

推广针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染的加强针是一个有待讨论的公开问题。公众对加强疫苗的意愿和影响因素知之甚少。一项针对中国成年人的横断面调查采用了在线问卷,该问卷是基于保护动机理论 (PMT) 量表和疫苗犹豫量表 (VHS) 设计的。分层多元回归用于比较 PMT 量表和 VHS 预测加强疫苗接种意愿的拟合度。多变量逻辑回归用于分析与接受相关的因素。6321 名(76.8%)参与者愿意接种加强针。然而,其余的参与者(23.2%)仍然对接种加强疫苗犹豫不决。PMT 量表在解释接种意愿方面比 VHS 更有效。感知严重性高的参与者(调整后的优势比[aOR]=0.69)和反应成本高的参与者(aOR=0.47)不太愿意接种加强针,但感知易感性高的参与者(aOR=1.19)、反应效果高的参与者(aOR=2.13)和自我效能高的参与者(aOR=3.33)更愿意接种加强针。总之,基于 PMT 的干预措施可以为确保加强疫苗的接受度提供指导。

相似文献

1
Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China.基于保护动机理论的 COVID-19 加强针接种接受度:中国的一项横断面研究。
J Med Virol. 2022 Sep;94(9):4115-4124. doi: 10.1002/jmv.27825. Epub 2022 May 9.
2
Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.基于健康信念模型(HBM)的中国老年人对 COVID-19 疫苗加强针的接受情况及其影响因素:一项全国性横断面研究。
Front Public Health. 2022 Dec 15;10:986916. doi: 10.3389/fpubh.2022.986916. eCollection 2022.
3
Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.用于促进未接种或对接种加强针犹豫不决的年轻成年人接种 COVID-19 疫苗的聊天机器人的疗效、可用性和可接受性:预-后试点研究。
J Med Internet Res. 2022 Oct 4;24(10):e39063. doi: 10.2196/39063.
4
Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.人们会接受第三剂 COVID-19 疫苗加强针吗?中国的一项横断面研究。
Front Public Health. 2022 Jul 12;10:914950. doi: 10.3389/fpubh.2022.914950. eCollection 2022.
5
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs.运用保护动机理论和阴谋信念预测 COVID-19 疫苗接种意愿。
Vaccine. 2021 Oct 8;39(42):6269-6275. doi: 10.1016/j.vaccine.2021.09.010. Epub 2021 Sep 7.
6
The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: A web-based cross-sectional survey.社交媒体使用与中国人对 COVID-19 疫苗加强针犹豫不决之间的关联:一项基于网络的横断面调查。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2065167. doi: 10.1080/21645515.2022.2065167. Epub 2022 Jun 7.
7
Using an extended protection motivation theory to explain vaccine hesitancy: a cross-sectional study among Chinese adults.利用扩展保护动机理论解释疫苗犹豫:一项针对中国成年人的横断面研究。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2026136. doi: 10.1080/21645515.2022.2026136. Epub 2022 Feb 1.
8
Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.中国儿童看护者对儿童接种 COVID-19 疫苗加强针的风险认知与接受度之间的关系。
Front Public Health. 2022 Mar 16;10:834572. doi: 10.3389/fpubh.2022.834572. eCollection 2022.
9
COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study.重点人群对 COVID-19 疫苗加强针的犹豫:一项横断面研究。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2166323. doi: 10.1080/21645515.2023.2166323. Epub 2023 Mar 23.
10
The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach.伊朗 COVID-19 疫苗接种意向的保护动机理论预测:结构方程建模方法。
BMC Public Health. 2021 Jun 17;21(1):1165. doi: 10.1186/s12889-021-11134-8.

引用本文的文献

1
Influencing factors and dynamic changes of COVID-19 vaccine hesitancy in China: From the perspective of machine learning analysis.中国新冠疫苗犹豫的影响因素及动态变化:基于机器学习分析视角
Hum Vaccin Immunother. 2025 Dec;21(1):2536898. doi: 10.1080/21645515.2025.2536898. Epub 2025 Jul 30.
2
Psychological distress and COVID-19 vaccine hesitancy among parents of in-school children after the end of the zero-COVID-19 policy: A city-wide survey in South China.新冠疫情防控政策结束后在校儿童家长的心理困扰与新冠疫苗接种犹豫:中国南方某市的一项全市范围调查
Hum Vaccin Immunother. 2025 Dec;21(1):2538942. doi: 10.1080/21645515.2025.2538942. Epub 2025 Jul 30.
3
Vaccination burnout impedes the compliance with multiple-dose administration of vaccines.疫苗接种倦怠阻碍了多剂次疫苗接种的依从性。
Sci Rep. 2025 Apr 17;15(1):13269. doi: 10.1038/s41598-025-97959-4.
4
Hesitancy towards COVID-19 booster vaccine among healthcare workers in Bangladesh.孟加拉国医护人员对新冠病毒加强疫苗的犹豫态度。
BMC Health Serv Res. 2025 Mar 6;25(1):346. doi: 10.1186/s12913-025-12482-6.
5
Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: a multicentre, prospective, longitudinal cohort study.中国中部地区对新型冠状病毒疾病首剂加强疫苗的体液免疫反应及突破性感染特征:一项多中心、前瞻性、纵向队列研究
Front Immunol. 2025 Jan 7;15:1446751. doi: 10.3389/fimmu.2024.1446751. eCollection 2024.
6
The effect of a self-learned virtual learning package on knowledge, attitude, and self-care behaviors of COVID-19 in people referred to health and treatment centers.自行学习的虚拟学习包对健康和治疗中心就诊人群的 COVID-19 知识、态度和自我护理行为的影响。
BMC Public Health. 2024 Jun 26;24(1):1710. doi: 10.1186/s12889-024-19233-y.
7
Preventive behaviors of respiratory infections in staff of hospital in Kazeroon, Fars, Iran: An application of protection motivation theory.伊朗法尔斯省卡泽伦医院工作人员呼吸道感染预防行为:保护动机理论的应用。
Clin Respir J. 2024 Jun;18(6):e13791. doi: 10.1111/crj.13791.
8
Healthcare workers' attitudes toward and factors influencing their acceptance of an annual COVID-19 booster vaccine: a cross-sectional study in Palestine.医护人员对年度 COVID-19 加强疫苗的态度及其影响因素:巴勒斯坦的一项横断面研究。
BMC Health Serv Res. 2024 May 14;24(1):624. doi: 10.1186/s12913-024-11016-w.
9
The Prevalence and Determinants of Hesitancy for Regular COVID-19 Vaccination among Primary Healthcare Patients with Asthma or COPD in Greece: A Cross-Sectional Study.希腊哮喘或慢性阻塞性肺疾病初级保健患者中新冠病毒常规疫苗接种犹豫的患病率及影响因素:一项横断面研究
Vaccines (Basel). 2024 Apr 14;12(4):414. doi: 10.3390/vaccines12040414.
10
Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review.全球新冠疫苗加强针接种接受度与犹豫情况的差异:最新叙述性综述
Vaccine X. 2024 Mar 23;18:100480. doi: 10.1016/j.jvacx.2024.100480. eCollection 2024 Jun.

本文引用的文献

1
COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis.低收入和中低收入国家对新冠疫苗的接受度:一项快速系统评价与荟萃分析
Vaccines (Basel). 2022 Mar 11;10(3):427. doi: 10.3390/vaccines10030427.
2
Applying an extended protection motivation theory to predict Covid-19 vaccination intentions and uptake in 50-64 year olds in the UK.运用扩展保护动机理论预测英国 50-64 岁人群对 COVID-19 疫苗接种的意愿和接种率。
Soc Sci Med. 2022 Apr;298:114819. doi: 10.1016/j.socscimed.2022.114819. Epub 2022 Feb 24.
3
Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy.意大利某大学社区接种新冠病毒疫苗加强针的意向
Vaccines (Basel). 2022 Jan 19;10(2):146. doi: 10.3390/vaccines10020146.
4
Lack of Access to Coronavirus Disease 2019 Vaccines Could Be a Greater Threat than Vaccine Hesitancy in Low-Income and Conflict Nations: The Case of Yemen.在低收入和冲突国家,无法获得 2019 年冠状病毒病疫苗可能比疫苗犹豫带来更大的威胁:以也门为例。
Clin Infect Dis. 2022 Nov 14;75(10):1827-1833. doi: 10.1093/cid/ciac088.
5
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.奥密克戎变异株的融合性和致病性减弱。
Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1.
6
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.巴西两剂科兴新冠疫苗(CoronaVac)既往接种者中异源与同源加强接种 COVID-19 疫苗(RHH-001):一项四期、非劣效性、单盲、随机研究。
Lancet. 2022 Feb 5;399(10324):521-529. doi: 10.1016/S0140-6736(22)00094-0. Epub 2022 Jan 21.
7
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.尽管接种了mRNA疫苗加强针,但仍出现了新冠病毒奥密克戎变异株突破性感染。
Lancet. 2022 Feb 12;399(10325):625-626. doi: 10.1016/S0140-6736(22)00090-3. Epub 2022 Jan 18.
8
Acceptance of a Third Dose of COVID-19 Vaccine and Associated Factors in China Based on Health Belief Model: A National Cross-Sectional Study.基于健康信念模型的中国新冠病毒疫苗第三剂接种接受情况及相关因素:一项全国性横断面研究
Vaccines (Basel). 2022 Jan 7;10(1):89. doi: 10.3390/vaccines10010089.
9
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England.英格兰 COVID-19 加强疫苗对与 COVID-19 相关症状、住院和死亡的有效性。
Nat Med. 2022 Apr;28(4):831-837. doi: 10.1038/s41591-022-01699-1. Epub 2022 Jan 14.
10
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study.同源 BBIBP-CorV 加强接种第三剂的安全性和免疫原性:一项前瞻性开放标签研究的中期结果。
Emerg Microbes Infect. 2022 Dec;11(1):639-647. doi: 10.1080/22221751.2022.2025746.